Objective: To report the rare development of manic symptoms in a patient with schizophrenia and discuss its differential diagnosis. Case description: Diagnostic criteria were based on the International Classification of Diseases, 10th edition (ICD-10). A 63-year-old female (diagnosed with schizophrenia since she was 28) was brought to the emergency room with symptoms consistent with manic episode and physical examination suggestive of thyrotoxicosis. Graves' disease was confirmed by subsequent laboratory tests. She was treated successfully with radioiodine ablation, leading to full remission of manic symptoms. Comments: Schizophrenia is a chronic disease that affects about 1% of the population worldwide. The main symptoms of the disorder are altered affection, delusions, and hallucinations. Graves' disease is an autoimmune condition in which antibodies increase the production and release of thyroid hormones. There are reports about the development of mood symptoms in patients with Graves' disease that remit with adequate treatment. Keywords: Schizophrenia, Graves' disease, mood symptoms, radioiodine, thyroid gland, schizoaffective disorder.
Introduction
Schizophrenia is a disorder of aberrant neurodevelopment with minor physical anomalies, neurological soft signs, and abnormalities of brain structure and function. 1 It is marked by deficits in both working memory and long-term memory tasks, disturbances in thinking, emotional reaction, and social behavior, including illusions and hallucinations. 1 Graves'
disease, in turn, was first described by Robert Graves in 1835 2 and has a prevalence of 1% in the general population. 3 The relationship between Graves' disease and psychiatric symptoms is known since the 19th century, when Parry & Graves described behavioral changes associated with hyperthyroidism, namely, dysphoria, anxiety, tremor, emotional lability, restlessness, fatigue, rapid speech, delirium, paranoia, and mania. 4 In 2010, Boelaert et al. assessed the coexistence of Graves' disease or Hashimoto's thyroiditis and other autoimmune diseases in 2,791 and 495 patients, respectively, and found coexisting disorders in 9.7%
of the former and in 14.3% of the latter. 5 The increase in free thyroxine (fT4) blood levels caused by Graves' disease has been shown to worsen and even cause many psychiatric symptoms, e.g., mania, anxiety, depression, and psychosis. 3 Delusions and hallucinations are both associated with changes in dopamine neurotransmission in patients with schizophrenia. [6] [7] [8] We report a rare case of development of manic symptoms in a female patient with schizophrenia who had never had mood symptoms before.
Case description
Written informed consent was obtained from the patient for publication of this case report.
A 63-year-old, thin, black female patient presented at the emergency room reporting euphoria, hyperthymia, racing thoughts, excessive talking, insomnia, increased goal-directed activity, aggressiveness, careless appearance, and delusions of being pregnant. The patient claimed that she wanted to go home with her husband and that she did not want to live with her relatives. The relatives informed that she had never been married or pregnant; nor did she have a history of manic episodes.
The family also denied alcohol or any drug consumption. Anti-TPO = anti-thyroperoxidase antibody; fT4 = free thyroxine; TRAb = anti-thyrotropin receptor antibody; TSH = thyroid-stimulating hormone.
psychotic patients with high fT4 levels and showing affective symptoms. However, she did not have a history of thyroid disease, and had never presented any mood symptoms before the current occasion.
Patients with schizoaffective disorder present symptoms characteristic of both schizophrenia and affective disorders. 18 In the case here described, both the patient's medical records and the family denied the occurrence of any affective symptom before. Indeed, while the patient's serum fT4 levels were high, her behavior was compatible with the diagnosis of schizoaffective disorder. However, the mood symptoms ceased after normalization of fT4 levels and withdrawal of valproate treatment. Also, manic symptoms did not reemerge after the withdrawal of sodium valproate, even while she was still hyperthyroiditic. These observations suggest that her psychiatric diagnosis falls somewhere on a continuum between schizophrenia and mood disorders.
18
The unique finding of this report is the development of affective symptoms during thyrotoxicosis in a patient previously diagnosed with schizophrenia.
Conclusion
High serum levels of thyroid hormones may be a feature of schizophrenia. Some studies have shown an association between altered thyroid hormones and a high level of oxidative stress in patients with schizophrenia. The high production of free radicals in schizophrenia is responsible for the increased level of thyroid hormones in these patients.
Graves' disease, the leading cause of thyrotoxicosis, is an autoimmune disease. According to Radhakrishnan et al., autoimmune thyroiditis is more commonly seen in patients with schizophrenia spectrum disorders when compared to those with mood disorders.
14 The present case report described the rare development of affective symptoms in a patient previously diagnosed with schizophrenia who developed Graves' disease at an advanced age. It is widely known that thyroid diseases can trigger psychiatric symptoms (e.g., anxiety, depression, mania, and psychosis) in previously healthy patients.
In psychotic patients, thyrotoxicosis can trigger other psychiatric symptoms or worsen the primary disease;
this finding justifies thyroid blood testing in psychotic patients. Further studies are necessary to elucidate the pathological process involved in these cases.
Discussion
Our search of the literature was performed using the PubMed/MEDLINE database, the Cochrane Database of Systematic Reviews, and textbooks. In Graves' disease, antibodies produced against TSH receptors cause an increase in thyroid hormone release. Graves' disease is the cause of 60-90% of all cases of thyrotoxicosis. 10, 11 The elevated fT4 levels observed in the condition are known to cause a myriad of psychiatric symptoms, including mania with psychotic features. 3, 4, 12, 13 The cooccurrence of endocrine and nervous system disorders has long been reported. 13 Patients meeting criteria for schizophrenia spectrum disorders have more autoimmune thyroid diseases than other psychiatric patients. 14 Also, hyperthyroidism is known to be highly frequent among patients over the age of 60, 15 and psychosis may be the first symptom of the disease. 16 for the oxidation of iodide into iodine, as well as for the production of thyroid hormones.
The study conducted by Akiibinu et al. found an association between overproduction of free radicals and increased levels of thyroid hormone in patients with schizophrenia, leading to hyperthyroidism. In our case, even though our patient was diagnosed with schizophrenia, a high level of TRAb was also found, allowing the diagnosis of Graves' disease to be confirmed (Table 1) .
Our patient could have been misdiagnosed as hyperthyroiditic with schizophrenia or schizoaffective disorder, which are the differential diagnoses for
